DÉRIVÉS DE QUINAZOLINONE SUBSTITUÉS EN 5 EN TANT QU'AGENTS ANTICANCÉREUX

• 收藏
• 分享

专利权人:

Celgene Corporation

发明人:

申请号：

EP17165492.4

公开号：

EP3239144A1

申请日:

2007.09.25

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

Provided herein is a compound of the formula:or a pharmaceutically acceptable salt or stereoisomer thereof. Also provided are said compound or a pharmaceutically acceptable salt or stereoisomer thereof or a pharmaceutical composition comprising said compound or said salt or stereoisomer for use in a method for treatment, management or prevention of various diseases and disorders as described herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/